Quantity and distribution of CD44+/CD24- cells in breast cancer tissue and the cell lines

Chinese Journal of Pathology

Volumn 38, Issue 7, 2009, Pages 441-444

  Lü, Xin Quan ^a   Zhenhe, Suo ^b   Ma, Chang Lu ^c   Xu, Ke Jia ^c   Liu, Yi Shan ^c   Li, Hui Xiang ^c  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c NONE

Author keywords

Antigens, CD24; Antigens, CD44; Breast neoplasms; Immunophenotyping; Tumor cells, cultured

Indexed keywords

CD24 ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; HERMES ANTIGEN; NUCLEOSIDE DIPHOSPHATE KINASE A; PROGESTERONE RECEPTOR; PROTEIN BCL 2; PROTEIN PS2; TUMOR MARKER;

AGE; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER CELL; CANCER CLASSIFICATION; CANCER INVASION; CELL STRAIN MCF 7; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MOLECULAR TYPING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; TUMOR VOLUME;

ADULT; AGED; ANTIGENS, CD24; ANTIGENS, CD44; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL LINE, TUMOR; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NM23 NUCLEOSIDE DIPHOSPHATE KINASES; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTOR, ERBB-2; RECEPTORS, PROGESTERONE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 70349105146     PISSN: 05295807     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0529-5807.2009.07.003     Document Type: Article

References (15)

1. González-Sarmiento R, Pérez-Losada J. Breast cancer, a stem cell disease. Curr Stem Cell Res Ther, 2008,3(1):55-65. (Pubitemid 352024868)
2. Wicha MS. Cancer stem cell heterogeneity in hereditary breast cancer. Breast Cancer Res, 2008,10(2):105.
3. Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A, 2003,100(7):3983-3988. (Pubitemid 36418143)
4. Hu Z, Fan C, Oh DS, et al. The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genomics, 2006,7:96. (Pubitemid 43786485)
5. Sørlie T, Wang Y, Xiao C, et al. Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms. BMC Genomics, 2006,7:127. (Pubitemid 44027496)
6. Yu K, Lee CH, Tan PH, et al. Conservation of breast cancer molecular subtypes and transcriptional patterns of tumor progression across distinct ethnic populations. Clin Cancer Res, 2004,10(16):5508-5517. (Pubitemid 39100489)
7. Fogel M, Friederichs J, Zeller Y, et al. CD24 is a marker for human breast carcinoma. Cancer Lett, 1999,143(1):87-94. (Pubitemid 29327194)
8. Rakha EA, El-Sayed ME, Green AR, et al. Breast carcinoma with basal differentiation: a proposal for pathology definition based on basal cytokeratin expression. Histopathology, 2007,50(4):434-438.
9. Shipitsin M, Campbell LL, Argani P, et al. Molecular definition of breast tumor heterogeneity. Cancer Cell, 2007,11(3):259-273. (Pubitemid 46349843)
10. Liu R, Wang X, Chen GY, et al. The prognostic role of a gene signature from tumorigenic breast cancer cells. N Engl J Med, 2007,356(3):217-226. (Pubitemid 46143225)
11. Fillmore CM, Kuperwasser C. Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy. Breast Cancer Res, 2008,10(2):R25.
12. Sheridan C, Kishimoto H, Fuchs RK, et al. CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis. Breast Cancer Res, 2006,8(5):R59. (Pubitemid 44804002)
13. Abraham BK, Fritz P, McClellan M, et al. Prevalence of CD44+/CD24-/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis. Clin Cancer Res, 2005,11(3):1154-1159. (Pubitemid 40175765)
14. Polyak K. Breast cancer: origins and evolution. J Clin Invest, 2007,117(11):3155-3163.